(Bloomberg) — Pfizer Inc. Chief Executive Officer Albert Bourla pocketed about $5.6 million after selling stock, the latest executive to reap the rewards of insider share transactions amid a vaccine-fueled rally for some pharmaceutical companies.Bourla disposed of more than 130,000 shares on Monday, according to a filing with the U.S. Securities and Exchange Commission. Sally Susman, executive vice president and chief corporate affairs officer at Pfizer, also offloaded about $1.8 million in stock.Pfizer’s shares soared that day after a report on results from its experimental vaccine with partner BioNTech SE. Anthony Fauci, the top U.S. infectious-disease specialist described the findings …read more
Source:: Yahoo Finance
